Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death worldwide, yet access to optimal lipid management and specialist care is still highly uneven across…
September 28-30, 2026, Ljubljana, Slovenia Organised by the EAS Paediatric Lipid Working Group Date: September 28-30, 2026Venue: University Children’s Hospital Ljubljana, SloveniaCourse director: Urh GroseljLanguage: English …
Sex-specific differences in cardiovascular risk factors and implications for cardiovascular disease prevention in women The lecture addresses how cardiovascular risk differs between women and men…
Prof. Dagmar Kratky is often called the “queen of lipid hydrolases” — and in this episode of AtheroTalk, she shares her passion for this fascinating…
What does it take to turn scientific evidence into healthcare policy that improves lives? In this AtheroTalk episode, we sit down with Prof. Zanfina Ademi,…
EAS warmly congratulates Professor Wiegman on his outstanding contribution to paediatric lipidology, particularly his pioneering work in familial hypercholesterolaemia and lifelong cardiovascular prevention. Read more
Familial hypercholesterolaemia (FH) is a common genetic disorder characterized by lifelong elevated low-density lipoprotein cholesterol (LDL-C) concentrations, which increase the risk of premature atherosclerotic cardiovascular…
Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death worldwide, responsible for one in three deaths globally. Despite major advances in lipid testing, preventive…
This episode of AtheroTalk features Prof. Raul Santos from Brazil, reflecting on his journey in cardiovascular medicine and his impact on the field of lipidology.…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
